Diagnostic, prognostic and predictive values of miR-100 and miR-210 in pediatric acute lymphoblastic Leukemia

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• MicroRNAs (miRNAs) are crucial regulators of gene expression.
• Dysregulation of miRNAs is implicated in various cancers, including pediatric acute lymphoblastic leukemia (ALL).
• Specific miRNAs may serve as biomarkers for ALL diagnosis and prognosis.

Purpose of the Study:

• To investigate the diagnostic and prognostic roles of miR-100 and miR-210 in pediatric ALL.
• To correlate miRNA expression levels with clinical features and patient outcomes.

Main Methods:

• Quantitative real-time polymerase chain reaction (qRT-PCR) was used to measure miR-100 and miR-210 expression in bone marrow aspirates.
• Samples were obtained from 85 pediatric ALL patients and 12 healthy controls.
• Expression data were analyzed for associations with clinico-pathological features, treatment response, disease-free survival (DFS), and overall survival (OS).

Main Results:

• miR-100 was significantly downregulated in pediatric ALL patients compared to controls (P=0.035).
• miR-210 was significantly upregulated in pediatric ALL patients compared to controls (P=0.025).
• miR-100 overexpression correlated with shorter DFS and OS (P=0.033 and P=0.046, respectively), and low miR-100 expression was linked to late death (P=0.024).
• No significant association was found between miR-210 expression and survival outcomes or death incidence.

Conclusions:

• miR-100 and miR-210 are potential diagnostic biomarkers for pediatric ALL.
• miR-100 demonstrates utility as a prognostic and predictive biomarker for childhood ALL.
• Further research is warranted to fully elucidate the clinical applications of these miRNAs in ALL management.